Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature

Psoriasis is a relatively common immune-mediated chronic inflammatory skin disease. It is well known that interferon-beta, a drug used in the management of relapsing-remitting multiple sclerosis, could exacerbate or induce de novo psoriasis. There is limited evidence in the literature based only on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambrianides, Sakis, Kinnis, Evgenios, Leonidou, Eleni, Pantzaris, Marios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180259/
https://www.ncbi.nlm.nih.gov/pubmed/30323758
http://dx.doi.org/10.1159/000492891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180259/
https://www.ncbi.nlm.nih.gov/pubmed/30323758
http://dx.doi.org/10.1159/000492891

Ejemplares similares